Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novantrone-Navelbine in Metastatic Hormone Refractory Prostate Cancer
NCT00006114Phase 2Unknown
- Sponsor
- GERCOR
- Start
- May 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2 trial of mitoxantrone and vinorelbine in prostate cancer (PCa), sponsored by GERCOR. Primary endpoints: Objective Response Rate, Progression-Free Survival and 3 more. Status: unknown.
02
Drugs
mitoxantronevinorelbine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00006114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006114.